Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 2/3 1Phase 1/2 1

Status

Unknown 5Recruiting 1

Sponsor Class

OTHER 33OTHER_GOV 5INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Rectal Neoplasms 3Stomach Neoplasms 2Adenocarcinoma 1

Interventions

apatinib 25Cisplatin 19Capecitabine 17Irinotecan 16Cyclophosphamide 15fludarabine 13Radiotherapy 12Oxaliplatin 12camrelizumab 11Paclitaxel 11Drug Therapy 11S 1 (combination) 10Carboplatin 10Fluorouracil 9Docetaxel 9Blood Specimen Collection 9Bevacizumab 9Radiation 7Pemetrexed 7Nivolumab 7Gemcitabine 7Erlotinib Hydrochloride 7tislelizumab 6Surgical Procedures, Operative 6Neoadjuvant Therapy 6Albumin-Bound Paclitaxel 6toripalimab 5XELOX 5Tamoxifen 5Propranolol 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × OTHER_GOV × XELOX × Clear all
NCT06227325 2024-01-26

Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression

Henan Cancer Hospital

Phase 2 Unknown
27 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03957733 2022-04-06

Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.

King Abdullah Medical City

Phase 2/3 Unknown
338 enrolled
Gastrointestinal

Rectal Neoplasms

NCT04747951 2021-02-15

Total Neoadjuvant Therapy in Rectal Cancer Treatment

State Scientific Centre of Coloproctology, Russian Federation

Phase 4 Unknown
280 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03599778 2018-07-26

XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma

Anhui Provincial Hospital

Phase 1/2 Unknown
52 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01952951 2017-09-13

PREPARE

National Cancer Center, Korea

Phase 2 Unknown
110 enrolled
Gastrointestinal

Adenocarcinoma, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡